A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort

2019 ◽  
Vol 34 (11) ◽  
pp. 1971-1978
Author(s):  
Raunak Jay Soman ◽  
Malisetty Venkat Swamy
Sign in / Sign up

Export Citation Format

Share Document